View Study [5]"Efficacy and safety of CagriSema in type 2 diabetes" Frias JP et al., 2023 Finding: In people with type 2 diabetes, CagriSema achieved 15.6% weight loss versus 5.1% with semaglutide alone over 32 weeks, with comparable HbA1c reductions and good tolerability
E., Czarnecki, S., Lai, H., Goodarzian, F., Shimada, H., and Reynolds, C
Medicare coverage limitations significantly impact usage patterns, with only 1% of adults over 65 using GLP-1 medications for weight loss compared to higher rates in younger populations ^19
As one of the top 10 glutathione brands in India, Now Foods Glutathione Capsules are certified and well tested by healthcare experts
Our approach is designed to promote sustainable fat reduction, enhance metabolic efficiency, and support overall health through the use of clinically validated medications tailored to each patients physiological needs